Tillkännagivande • Jul 28
Vireo Growth Inc. (CNSX:VREO) entered into a definitive merger agreement to acquire Planet 13 Holdings Inc. (CNSX:PLTH) for $51.9 million. Vireo Growth Inc. (CNSX:VREO) entered into a definitive merger agreement to acquire Planet 13 Holdings Inc. (CNSX:PLTH) for $51.9 million on July 26, 2026. Under the terms of the agreement, each issued and outstanding share of common stock of Planet 13 will be converted into the right to receive 0.015 of a Vireo subordinate voting share. The price represents a 16.6% premium over Planet 13’s 20-day volume weighted average price per share as of July 24, 2026, the last trading day before the execution of the Merger Agreement. In case of termination of transaction, Planet 13 Holdings will pay a termination fee of $1.80 million.
The transaction is subject to closing conditions, including obtaining Planet 13 stockholder approval, the effectiveness of a registration statement on Form S-4 to be filed with the U.S. Securities and Exchange Commission, approval of the listing of the Vireo shares issuable in the
Transaction by the Canadian Securities Exchange, and applicable cannabis regulatory approvals. The Board of Directors of Planet 13 Holdings Inc. formed a special committee for the transaction. The deal has been unanimously approved by the board of both companies. Upon completion of the transaction, it is expected that the Planet 13 shares of common stock will be delisted from the Canadian Securities Exchange and withdrawn from the OTCQX Market and that Planet 13 will apply to cease to be a reporting issuer under applicable United States
and Canadian securities laws.
ATB Cormark Capital Markets acted as financial advisor and fairness opinion provider to the Special Committee. Eversheds Sutherland (US) LLP and DLA Piper (Canada) LLP acted as legal advisors to Vireo. Cozen O’Connor is serving as legal advisor to Planet 13. Foley Hoag LLP is serving as legal advisor to the Special Committee New Risk • May 28
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Canadian stocks, typically moving 18% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (18% average weekly change). Minor Risks Less than 1 year of cash runway based on current free cash flow (-US$14m). Currently unprofitable and not forecast to become profitable over next 2 years (US$5.1m net loss in 2 years). Market cap is less than US$100m (CA$69.0m market cap, or US$49.8m). Major Estimate Revision • May 20
Consensus EPS estimates fall by 22% The consensus outlook for earnings per share (EPS) in fiscal year 2026 has deteriorated. 2026 revenue forecast decreased from US$92.6m to US$89.2m. Losses expected to increase from US$0.03 per share to US$0.037. Pharmaceuticals industry in Canada expected to see average net income growth of 60% next year. Consensus price target broadly unchanged at CA$0.28. Share price fell 5.1% to CA$0.18 over the past week. Tillkännagivande • May 20
Planet 13 Holdings Inc. Receives Ommu Approval for Florida Bho Extraction Facility Planet 13 Holdings Inc. announced that its Florida operations have received approval from the Florida Office of Medical Marijuana Use for its BHO extraction facility. The approval completes the final major infrastructure investment in Planet 13 Florida's operational buildout and enables the Company to serve Florida's full concentrate category for the first time. The approximately 3,465-square-foot purpose-built laboratory supports production of six BHO concentrate formats: Badder, Shatter, Crumble, Sugar, Sauce, and Diamonds, as well as Live Resin Disposable and C-Cell vaporizer cartridges. Products will be available at Planet 13 Florida dispensary locations in the coming months as products are approved. According to Headset market data, Florida's concentrate segment generated approximately $125 million in retail sales, a category in which Planet 13 Florida's participation was previously limited. Breakeven Date Change • May 17
No longer forecast to breakeven The 3 analysts covering Planet 13 Holdings no longer expect the company to break even during the foreseeable future. The company was expected to make a profit of US$1.10m in 2028. New consensus forecast suggests the company will make a loss of US$1.20m in 2028. Reported Earnings • May 14
First quarter 2026 earnings: EPS and revenues miss analyst expectations First quarter 2026 results: US$0.025 loss per share (further deteriorated from US$0.006 loss in 1Q 2025). Revenue: US$21.1m (down 25% from 1Q 2025). Net loss: US$8.10m (loss widened 296% from 1Q 2025). Revenue missed analyst estimates by 7.6%. Earnings per share (EPS) also missed analyst estimates by 50%. Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 7.7% growth forecast for the Pharmaceuticals industry in Canada. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has fallen by 39% per year, which means it is significantly lagging earnings. Tillkännagivande • May 07
Planet 13 Holdings Inc. Appoints Nancy Saitta and Leilani Bradford to Board of Directors, Effective April 24, 2026 Planet 13 Holdings Inc. announced the appointment of the Honorable Nancy Saitta and Leilani Bradford as independent directors, filling two newly created seats on the Board, effective April 24, 2026.Justice Saitta brings two decades of judicial experience, including service as Chief Justice of the Nevada Supreme Court. Ms. Bradford brings more than 20 years of real estate finance and transaction structuring experience. Both appointments expand the independent representation on the Board and add depth in governance, legal oversight and real estate. Both directors have been appointed to the Audit Committee, Compensation Committee, and Corporate Governance and Nominating Committee. Justice Saitta served as a member of the Nevada judiciary for 20 years, including as a Justice of the Nevada Supreme Court from 2007 to 2016 and as Chief Justice from 2011 to 2012. Prior to her service on the Nevada Supreme Court, she served as a Judge of the Eighth Judicial District Court in Nevada from 1998 to 2006 and as a Judge of the Las Vegas Municipal Court from 1996 to 1998. Earlier in her career, she served as a Senior Deputy Attorney General and Children's Advocate for the State of Nevada and practiced law in private practice. Since 2017, Justice Saitta has served with Advanced Resolution Management as a mediator, arbitrator, special master, consultant and private judge, and continues to serve as a Senior District Judge for the Nevada Supreme Court on an as-needed basis. Justice Saitta received a J.D. from Wayne State University Law School and a B.S. from Wayne State University. Ms. Bradford has served as a Principal and Director of SHEQ Properties, a Las Vegas based real estate company, since 2005. She brings over 20 years of experience in the real estate industry, with expertise in finance, underwriting, transaction structuring and client relationship management. During her tenure at SHEQ, she has played a key role in sourcing, underwriting and structuring transactions, particularly in the medical and professional property sectors, and in developing the company's Shared Equity Model, which provides ownership opportunities to physicians and service providers in connection with long-term lease arrangements. Prior to joining SHEQ, Ms. Bradford built a career in accounting and finance. She is a Certified Public Accountant and received a Bachelor's degree in Accounting from the University of Nevada, Reno. Tillkännagivande • May 06
Planet 13 Holdings Inc. to Report Q1, 2026 Results on May 13, 2026 Planet 13 Holdings Inc. announced that they will report Q1, 2026 results After-Market on May 13, 2026 Tillkännagivande • May 02
Planet 13 Holdings Inc., Annual General Meeting, Jun 10, 2026 Planet 13 Holdings Inc., Annual General Meeting, Jun 10, 2026. New Risk • Apr 22
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Canadian stocks, typically moving 16% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Less than 1 year of cash runway based on current free cash flow (-US$21m). Share price has been volatile over the past 3 months (16% average weekly change). Market cap is less than US$100m (CA$65.7m market cap, or US$48.0m). Breakeven Date Change • Mar 27
Forecast to breakeven in 2028 The 3 analysts covering Planet 13 Holdings expect the company to break even for the first time. New consensus forecast suggests losses will reduce by 79% per year to 2027. The company is expected to make a profit of US$1.10m in 2028. Average annual earnings growth of 121% is required to achieve expected profit on schedule. Breakeven Date Change • Mar 26
Forecast to breakeven in 2028 The 3 analysts covering Planet 13 Holdings expect the company to break even for the first time. New consensus forecast suggests the company will make a profit of US$1.10m in 2028. Average annual earnings growth of 86% is required to achieve expected profit on schedule. Tillkännagivande • Mar 19
Planet 13 Holdings Inc. to Report Fiscal Year 2025 Results on Mar 25, 2026 Planet 13 Holdings Inc. announced that they will report fiscal year 2025 results After-Market on Mar 25, 2026 Tillkännagivande • Feb 13
An undisclosed buyer completed the acquisition of Non-Core Orange County Store from Planet 13 Holdings Inc. (CNSX:PLTH). An undisclosed buyer acquired Non-Core Orange County Store from Planet 13 Holdings Inc. (CNSX:PLTH) on November 3, 2025. Planet 13’s California operations, which represented a small portion of the Planet 13’s overall revenue, were cash-flow negative and no longer aligned with Planet 13’s long-term objectives. Proceeds from the transaction, while not material, will help further strengthen the Planet 13’s balance sheet, liquidity and enable investment in core markets.
The sale is subject to customary closing conditions and regulatory approvals. The closing of the transaction is expected within approximately three to four months. As of November 12, 2025, Planet 13 Holdings Inc. expects to have divested all California operations by early first quarter of 2026.
An undisclosed buyer completed the acquisition of Non-Core Orange County Store from Planet 13 Holdings Inc. (CNSX:PLTH) on February 12, 2026. Board Change • Feb 03
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Kevin Martin was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Tillkännagivande • Jan 09
Planet 13 Holdings Inc. Places Chief Administrative Officer, Lee Fraser on Administrative Leave, Effective January 5, 2026 Planet 13 Holdings Inc. placed the Company's Chief Administrative Officer, Lee Fraser, on administrative leave effective January 5, 2026. Tillkännagivande • Nov 04
Planet 13 Holdings Inc. to Report Q3, 2025 Results on Nov 12, 2025 Planet 13 Holdings Inc. announced that they will report Q3, 2025 results After-Market on Nov 12, 2025 Tillkännagivande • Nov 03
Planet 13 Streamlines Footprint to Focus on Core Growth Markets Planet 13 Holdings Inc. announced the divestiture of its non-core Orange County, California retail store and the closure of its cultivation facility in Coalinga, California. These actions mark another step in Planet 13's strategy to focus resources on its highest-performing markets and to position the Company for long-term growth and profitability. Planet 13 will continue to invest in expanding its presence in Nevada and Florida while pursuing disciplined opportunities that enhance shareholder value. The Company's California operations, which represented a small portion of the Company's overall revenue, were cash-flow negative and no longer aligned with Planet 13's long-term objectives. Proceeds from the transaction, while not material, will help further strengthen the Company's balance sheet, liquidity and enable investment in core markets. The sale of the Orange County retail license is subject to customary closing conditions and regulatory approvals. The Company expects the transaction to close within approximately three to four months. The Coalinga facility is expected to wind down operations by the end of 2025. Buy Or Sell Opportunity • Oct 30
Now 21% undervalued The stock has been flat over the last 90 days, currently trading at CA$0.28. The fair value is estimated to be CA$0.36, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 2.5% over the last 3 years. Earnings per share has grown by 4.1%. Revenue is forecast to grow by 0.2% in 2 years. Earnings are forecast to grow by 74% in the next 2 years. Tillkännagivande • Sep 09
Planet 13 Holdings Inc. Announces Nano HaHa Soft Chews Now Available in Florida at Planet 13 Dispensaries Across the Sunshine State Planet 13 Holdings Inc. announced Nano HaHa Soft Chews are now available at all of its Planet 13 stores across Florida. Nano HaHa Soft Chew Flavors: Strawberry Lemonade (100mg THC); Mighty Mango (100mg THC), Blue Razz (100mg THC); Blue Razz 1:1 ratio (50mg THC + 50mg CBD); Guava Breeze 1:1 ratio (50 mg THC + 50mg CBD); Sugar-free gummies are popular among health-conscious individuals and are ideal for those who enjoy or manage a low-sugar lifestyle. On top of HaHa, Planet 13 is planning to introduce its delicious and popular Dreamland Chocolates in Florida this September. Decadent and dreamy, Dreamland is luxury chocolate infused with premium cannabis and hand-crafted flavors. Recent Insider Transactions Derivative • Aug 15
Vice President of Operations notifies of intention to sell stock Christopher Wren intends to sell 3m shares in the next 90 days after lodging an Intent To Sell Form on the 15th of August. If the sale is conducted around the recent share price of CA$0.48, it would amount to CA$1.4m. Since March 2025, Christopher has owned 3.97m shares directly. There has only been one transaction (CA$20k purchase) from insiders over the last 12 months. New Risk • Aug 15
New major risk - Revenue and earnings growth Earnings have declined by 24% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (20% average weekly change). Earnings have declined by 24% per year over the past 5 years. Minor Risk Market cap is less than US$100m (CA$188.7m market cap, or US$136.7m). Reported Earnings • Aug 14
Second quarter 2025 earnings: EPS and revenues miss analyst expectations Second quarter 2025 results: US$0.041 loss per share (further deteriorated from US$0.028 loss in 2Q 2024). Revenue: US$26.9m (down 14% from 2Q 2024). Net loss: US$13.3m (loss widened 65% from 2Q 2024). Revenue missed analyst estimates by 4.8%. Earnings per share (EPS) also missed analyst estimates by 33%. Revenue is forecast to grow 7.3% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Pharmaceuticals industry in Canada. Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 42% per year, which means it is significantly lagging earnings. Tillkännagivande • Aug 07
Planet 13 Holdings Inc. Announces the Launch of Planet the 13th Night Market Planet 13 Holdings Inc. announced the launch of Planet the 13th Night Market--a new indoor art and makers market taking place the 13th of every month in the Planet 13 Entertainment Complex. The first event launches Wednesday, August 13, 2025, from 6-10 p.m. at Planet 13, the dispensary, located at 2548 W. Desert Inn Road, Las Vegas. This 21+ event is free and open to the public. Highlights of the launch event include: Local artists & Makers - one-of-a-kind art, handmade goods, and creative products, all while experiencing the energy, spectacle and interactive entertainment of Planet 13. Calling All Creators: Local artists, craftspeople, and makers are invited to apply for upcoming Night Markets. Booth fees are waived, but each participant must provide a free interactive element for attendees. Space is curated and limited. Tillkännagivande • Jul 21
Planet 13 Holdings Inc. to Report Q2, 2025 Results on Aug 13, 2025 Planet 13 Holdings Inc. announced that they will report Q2, 2025 results After-Market on Aug 13, 2025 New Risk • May 15
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -US$2.1m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-US$2.1m free cash flow). Minor Risks Currently unprofitable and not forecast to become profitable next year (US$755k net loss next year). Share price has been volatile over the past 3 months (16% average weekly change). Market cap is less than US$100m (CA$120.3m market cap, or US$86.2m). Tillkännagivande • May 07
Planet 13 Holdings Inc. to Report Q1, 2025 Results on May 14, 2025 Planet 13 Holdings Inc. announced that they will report Q1, 2025 results After-Market on May 14, 2025 New Risk • Apr 08
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Canadian stocks, typically moving 14% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 33% per year over the past 5 years. Shareholders have been substantially diluted in the past year (34% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (14% average weekly change). Market cap is less than US$100m (CA$81.3m market cap, or US$57.1m). Reported Earnings • Mar 27
Full year 2024 earnings: EPS and revenues miss analyst expectations Full year 2024 results: US$0.16 loss per share (improved from US$0.33 loss in FY 2023). Revenue: US$116.4m (up 18% from FY 2023). Net loss: US$47.8m (loss narrowed 35% from FY 2023). Revenue missed analyst estimates by 1.7%. Earnings per share (EPS) also missed analyst estimates by 23%. Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has fallen by 49% per year, which means it is performing significantly worse than earnings. Tillkännagivande • Mar 27
Planet 13 Holdings Inc. Announces Impairment Results for the Fourth Quarter Ended December 31, 2024 Planet 13 Holdings Inc. announced impairment results for the fourth quarter ended December 31, 2024. For the quarter, the company reported Impairment of goodwill and other intangibles of $18.9 million as compared to $7.2 million reported a year ago. Tillkännagivande • Mar 19
Planet 13 Holdings Inc. to Report Q4, 2024 Results on Mar 26, 2025 Planet 13 Holdings Inc. announced that they will report Q4, 2024 results After-Market on Mar 26, 2025 Tillkännagivande • Mar 10
Planet 13 Holdings Inc., Annual General Meeting, Jun 10, 2025 Planet 13 Holdings Inc., Annual General Meeting, Jun 10, 2025. New Risk • Mar 05
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: CA$143.1m (US$99.5m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$6.9m free cash flow). Earnings have declined by 38% per year over the past 5 years. Shareholders have been substantially diluted in the past year (34% increase in shares outstanding). Minor Risk Market cap is less than US$100m (CA$143.1m market cap, or US$99.5m). New Risk • Jan 16
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 46% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$6.9m free cash flow). Earnings have declined by 38% per year over the past 5 years. Shareholders have been substantially diluted in the past year (46% increase in shares outstanding). Reported Earnings • Nov 10
Third quarter 2024 earnings released: US$0.023 loss per share (vs US$0.21 loss in 3Q 2023) Third quarter 2024 results: US$0.023 loss per share (improved from US$0.21 loss in 3Q 2023). Revenue: US$32.2m (up 30% from 3Q 2023). Net loss: US$7.41m (loss narrowed 84% from 3Q 2023). Revenue is forecast to grow 38% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Pharmaceuticals industry in Canada. Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has fallen by 49% per year, which means it is performing significantly worse than earnings. Tillkännagivande • Nov 07
Planet 13 Holdings Inc. Appoints Jillian Austin as National Head of Marketing Experiences Planet 13 Holdings Inc. announced the hiring of Jillian Austin as National Head of Marketing Experiences. Jillian Austin brings a wealth of experience as Planet 13 and its new Lifestyles business accelerate growth by becoming a national brand. As Director of Brand Partnerships at AREA15, an immersive entertainment district in Las Vegas, she led collaborations with global brands like Netflix, Disney, Amazon, and Tesla spearheading immersive experiences and lifestyle branding. Jillian has over 17 years of experience in immersive & transmedia storytelling, creative strategy, and experiential marketing. She has been responsible for events, brand and marketing for Tao Group, ESPN/Disney and other high-profile hospitality and entertainment companies. Tillkännagivande • Nov 01
Planet 13 Holdings Inc. to Report Q3, 2024 Results on Nov 08, 2024 Planet 13 Holdings Inc. announced that they will report Q3, 2024 results After-Market on Nov 08, 2024 Reported Earnings • Aug 09
Second quarter 2024 earnings released: US$0.028 loss per share (vs US$0.02 loss in 2Q 2023) Second quarter 2024 results: US$0.028 loss per share (further deteriorated from US$0.02 loss in 2Q 2023). Revenue: US$31.1m (up 20% from 2Q 2023). Net loss: US$8.07m (loss widened 86% from 2Q 2023). Revenue is forecast to grow 37% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Pharmaceuticals industry in Canada. Over the last 3 years on average, earnings per share has fallen by 39% per year but the company’s share price has fallen by 53% per year, which means it is performing significantly worse than earnings. Tillkännagivande • Jul 22
Planet 13 Holdings Inc. to Report Q2, 2024 Results on Aug 08, 2024 Planet 13 Holdings Inc. announced that they will report Q2, 2024 results After-Market on Aug 08, 2024 Tillkännagivande • Jun 14
Planet 13 Holdings Inc. Announces Appointment of David Loop to Board of Directors Planet 13 Holdings Inc. announced the appointment of David Loop, the former Chief Executive Officer of VidaCann LLC to Planet 13's board of directors. David Loop has spent his entire career in the horticulture industry, including as CEO of Loop Nursery. As CEO of Loop Nursery, he played a pivotal role in its expansion to become the largest supplier of potted plants to supermarkets across the Southeast United States, while simultaneously establishing it as one of the premier greenhouse facilities in the United States. David was instrumental in founding VidaCann and spearheading its growth into the 9th largest Florida retail network. Under his guidance, VidaCann has experienced remarkable per store revenue growth over the past two years, solidifying its position as a leader in the state. David Loop was nominated by VidaCann to join the board of directors of Planet 13 as part of the acquisition of VidaCann by Planet 13. Concurrently Lee Fraser will step down from the board of directors to focus on his role as Chief Administrative Officer of Planet 13. Reported Earnings • May 10
First quarter 2024 earnings released: US$0.026 loss per share (vs US$0.029 loss in 1Q 2023) First quarter 2024 results: US$0.026 loss per share (improved from US$0.029 loss in 1Q 2023). Revenue: US$22.9m (down 8.2% from 1Q 2023). Net loss: US$5.87m (loss narrowed 6.8% from 1Q 2023). Over the last 3 years on average, earnings per share has fallen by 38% per year but the company’s share price has fallen by 52% per year, which means it is performing significantly worse than earnings. Tillkännagivande • May 03
Planet 13 Holdings Inc. to Report Q1, 2024 Results on May 09, 2024 Planet 13 Holdings Inc. announced that they will report Q1, 2024 results After-Market on May 09, 2024 Tillkännagivande • Apr 30
Planet 13 Holdings Inc. Launches New Medizin Branded Topicals Planet 13 Holdings Inc. has unveiled its latest innovation with the launch of its new CBD hemp and cannabis derived topical line under the esteemed MEDIZIN brand. These products will be available in store, reach customers through wholesale channels and the hemp derived products will be available online, marking an exciting expansion of Planet 13's product offerings. The cannabis derived MEDIZIN topicals will be manufactured at the Planet 13 SuperStore in the production facility where visitors can watch products being made, further enhancing the immersive customer experience that Planet 13 is renowned for. Planet 13's MEDIZIN topicals will incorporate Ovation Science Inc.'s patented skin delivery technology Invisicare®?. With over 20 years of research and development behind it, Invisicare facilitates enhanced delivery of CBD, THC, and other cannabinoids through the skin. In a recent in-house study, Ovation compared five leading CBD brands to their own topical CBD cream. The results showed that competitor cream released less than 2% CBD, while Ovation Science's formulation achieved an impressive 40% release rate. The new topicals that are now available include: MEDIZIN REST: 3:1 Ratio - 375mg CBD & 125mg THC - A CBD-infused transdermal cream crafted to alleviate soreness and discomfort to foster relaxation for a restful night's sleep. MEDIZIN RECOVERY: 1:1 Ratio - 250mg CBD & 250mg THC - An ideal blend of CBD and THC to unlock the combined benefits of both cannabinoids to conjure the entourage effect. MEDIZIN RELIEF: 1:10 Ratio - 50mg CBD & 500mg THC - A THC-dominant transdermal cream designed to provide relief, complemented by CBD to balance the effects. PLET 13 PURE CBD: Planet 13 PURE CBD with 400mg CBD per jar. A transdermal CBD cream designed to provide relief and promote relaxation. Recent Insider Transactions Derivative • Mar 27
Co-Chairman & Co-CEO exercised options to buy CA$128k worth of stock. On the 22nd of March, Robert Groesbeck exercised 281.26k options to receive shares at no cost, then sold around 125.58k of them at CA$0.71 each and kept the remainder. Since June 2023, Robert's direct individual holding has decreased from 39.26m shares to 38.26m. Company insiders have collectively bought CA$602k more than they sold, via options and on-market transactions, in the last 12 months. New Risk • Mar 15
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -US$21m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$21m free cash flow). Earnings have declined by 45% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Shareholders have been diluted in the past year (9.3% increase in shares outstanding). New Risk • Mar 06
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 9.3% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 45% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (14% average weekly change). Shareholders have been diluted in the past year (9.3% increase in shares outstanding). Tillkännagivande • Mar 06
Planet 13 Holdings Inc. has completed a Composite Units Offering in the amount of $11.25 million. Planet 13 Holdings Inc. has completed a Composite Units Offering in the amount of $11.25 million.
Security Name: Units
Security Type: Equity/Derivative Unit
Securities Offered: 18,750,000
Price\Range: $0.6
Discount Per Security: $0.036 Reported Earnings • Feb 29
Full year 2023 earnings released: US$0.33 loss per share (vs US$0.28 loss in FY 2022) Full year 2023 results: US$0.33 loss per share (further deteriorated from US$0.28 loss in FY 2022). Revenue: US$98.5m (down 5.8% from FY 2022). Net loss: US$73.6m (loss widened 24% from FY 2022). Over the last 3 years on average, earnings per share has fallen by 34% per year but the company’s share price has fallen by 50% per year, which means it is performing significantly worse than earnings. Tillkännagivande • Feb 28
Planet 13 Holdings Inc. to Report Q4, 2023 Results on Mar 13, 2024 Planet 13 Holdings Inc. announced that they will report Q4, 2023 results on Mar 13, 2024 New Risk • Feb 12
New major risk - Revenue and earnings growth Earnings have declined by 44% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 44% per year over the past 5 years. Minor Risk Significant insider selling over the past 3 months (CA$109k sold). Board Change • Feb 11
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Independent Director Adrienne O’Neal was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Tillkännagivande • Feb 08
Planet 13 Announces Expansion of Leadership Team and Board Planet 13 Holdings Inc. announced the appointments of Lee Fraser to the role of Chief Administrative Officer, Tatev Oganyan to General Counsel and Kevin Martin to the Company's board of directors. The appointments reaffirm Planet 13's commitment to governance, compliance, financial security, and leadership strength and depth. As Chief Administrative Officer, Lee Fraser will be responsible for strategic planning, sales and purchasing, operations management, risk management and compliance. The role matches Mr. Fraser's strengths, developed over 20 plus years as a finance & operations executive at several publicly traded companies. His experience overseeing large-scale growth projects and large teams across many different states and countries for companies such as Warner Bros and Fox Corp. will be key in Planet 13's next phase of growth. As a Board Member, Kevin Martin will apply his knowledge and experience from a career in internal audit at large private and public companies to implementing best practices to improve Planet 13's governance, financial practices, and audit and financial procedures. Martin holds a CPA, CFE, and CRMA designations with 22 years of experience in internal audit and operational experience. As General Counsel, Tatev Oganyan will serve as the primary legal advisor to management and the board while overseeing legal matters for the Company. In her role as regulatory counsel at Planet 13, Tatev led the licensing and permitting process for the successful opening of the Planet 13 Orange County and Planet 13 Waukegan stores. She further led the regulatory due diligence for the Next Green Wave acquisition, allowing Planet 13 to broaden its popular brand portfolio in California. Before joining Planet 13, Tatev established a leading practice, specializing in cannabis law, licensing, and regulatory compliance for premium cannabis brands. Tillkännagivande • Jan 24
Planet 13 Holdings Inc., Annual General Meeting, Jun 11, 2024 Planet 13 Holdings Inc., Annual General Meeting, Jun 11, 2024, at 12:00 Pacific Daylight. Location: the Company's offices located at 2548 West Desert Inn Road Las Vegas Nevada United States Agenda: To consider proposals intended to be included in the Company's proxy statement under Rule 14a-8 promulgated under the Exchange Act; and to consider other matters. Tillkännagivande • Nov 29
Planet 13 Holdings Inc. announced that it has received $0.71 million in funding On November 27, 2023, Planet 13 Holdings Inc. closed the transaction. The transaction included participation from two investors. New Risk • Nov 29
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -US$15m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$15m free cash flow). Share price has been highly volatile over the past 3 months (19% average weekly change). Minor Risks Currently unprofitable and not forecast to become profitable next year (US$14m net loss next year). Significant insider selling over the past 3 months (CA$700k sold). Recent Insider Transactions Derivative • Nov 16
Vice President of Operations notifies of intention to sell stock Christopher Wren intends to sell 150k shares in the next 90 days after lodging an Intent To Sell Form on the 13th of November. If the sale is conducted around the recent share price of CA$1.19, it would amount to CA$178k. Since March 2023, Christopher's direct individual holding has decreased from 4.24m shares to 4.06m. Company insiders have collectively bought CA$242k more than they sold, via options and on-market transactions, in the last 12 months. Tillkännagivande • Nov 16
Planet 13 and Next Green Wave Holdings Inc Enters into Settlement Agreement Planet 13 Holdings Inc. announced that it has entered into a settlement agreement on November 14, 2023 with certain individuals with respect to certain claims advanced by the SDC Parties against Next Green Wave Holdings Inc. As a result of the Company's acquisition of NGW on March 2, 2022, the Company assumed all liabilities of NGW. Pursuant to the Settlement Agreement, in consideration for the SDC Parties releasing the Planet 13 Parties from claims relating to the Legal Actions and to avoid the further expense of litigation, the Company agreed to pay the SDC Parties a cash payment of $300,000 in the aggregate and issue the SDC Parties an aggregate of 1,000,000 shares of common stock in the capital of the Company. The Cash Payment will be made and the Settlement Shares will be issued on the date that is 14 days from the date of signing of the Settlement Agreement. Reported Earnings • Nov 10
Third quarter 2023 earnings: EPS and revenues miss analyst expectations Third quarter 2023 results: US$0.21 loss per share (further deteriorated from US$0.028 loss in 3Q 2022). Revenue: US$24.8m (down 3.3% from 3Q 2022). Net loss: US$46.0m (loss widened US$39.7m from 3Q 2022). Revenue missed analyst estimates by 4.7%. Earnings per share (EPS) also missed analyst estimates. Revenue is forecast to grow 43% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Pharmaceuticals industry in Canada. Over the last 3 years on average, earnings per share has fallen by 37% per year whereas the company’s share price has fallen by 39% per year. Tillkännagivande • Nov 01
Planet 13 Holdings Inc. to Report Q3, 2023 Results on Nov 08, 2023 Planet 13 Holdings Inc. announced that they will report Q3, 2023 results After-Market on Nov 08, 2023 New Risk • Nov 01
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Canadian stocks, typically moving 18% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (18% average weekly change). Minor Risks Currently unprofitable and not forecast to become profitable next year (US$16m net loss next year). Significant insider selling over the past 3 months (CA$591k sold). Recent Insider Transactions • Sep 10
Vice President of Operations recently sold CA$248k worth of stock On the 5th of September, Christopher Wren sold around 200k shares on-market at roughly CA$1.24 per share. This transaction amounted to 4.6% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Christopher has been a net seller over the last 12 months, reducing personal holdings by CA$250k. Recent Insider Transactions Derivative • Sep 01
Vice President of Operations notifies of intention to sell stock Christopher Wren intends to sell 100k shares in the next 90 days after lodging an Intent To Sell Form on the 30th of August. If the sale is conducted around the recent share price of CA$0.77, it would amount to CA$77k. Since March 2023, Christopher's direct individual holding has increased from 4.24m shares to 4.34m. Company insiders have collectively bought CA$490k more than they sold, via options and on-market transactions, in the last 12 months. Tillkännagivande • Aug 29
Planet 13 Holdings Inc. (CNSX:PLTH) entered into a membership interest purchase agreement to acquire VidaCann Ltd. for $48.8 million. Planet 13 Holdings Inc. (CNSX:PLTH) entered into a membership interest purchase agreement to acquire VidaCann Ltd. for $48.8 million on August 28, 2023. Pursuant to the Purchase Agreement, Planet 13 Holdings Inc. (the “Company”) will acquire VidaCann from the Sellers for agreed consideration equal to the sum of: (i) 78,461,538 common shares in the capital of the Company (the “Base Share Consideration”); (ii) a cash payment of $4,000,000 (the “Closing Cash Payment”); and (iii) promissory notes to be issued by the Company to the Sellers in the aggregate principal amount of $5,000,000, with each of the above components subject to adjustments as set out in the Purchase Agreement. The total consideration is valued at approximately $48.9 million. The Purchase Agreement contemplates that VidaCann will continue to have $3,000,000 of bank indebtedness and $1,500,000 or less of related party notes to former VidaCann owners at the time of closing. Pursuant to the Purchase Agreement, 1,307,698 shares comprising the Base Share Consideration will be issued to VidaCann’s industry advisor, 9496 7346 Quebec Inc. on closing. The proposed transaction is an arm’s length transaction. Post-transaction, the former equityholders of VidaCann, along with the VC Advisor, will have approximately 26.09% pro forma ownership in Planet 13 on a fully diluted basis, before factoring in any adjustments to the Base Share Consideration. All shares issued by the Company will be subject to resale restrictions under applicable U.S. and Canadian securities laws. Furthermore, each Seller and each equityholder of a Seller that holds over 5% in direct or indirect interest in VidaCann and receives Base Share Consideration will be subject to a lock-up agreement restricting trading of the shares received, with the release of one-third of shares from such restrictions six months following closing and each subsequent six months thereafter.
The proposed transaction is expected to close in, or immediately prior to, the first quarter of 2024, subject to customary closing conditions, including the receipt of approval from the applicable state cannabis regulators and the sale of the Company's Medical marijuana Treatment Center license in Florida to a third party, including any regulatory approvals required to effectuate the sale. The terms of the proposed transaction were negotiated by management and advisors under guidance of, and unanimously recommended for approval by, the Board. The Board has received a fairness opinion from Evans & Evans, Inc. The proposed transaction has been unanimously approved by the Board of Planet 13 and the managers of VidaCann. Canaccord Genuity Corp. is acting as financial advisor to Planet 13 and Cozen O’Connor P.C. and Wildeboer Dellelce LLP are acting as U.S. and Canadian legal advisor, respectively. Evans & Evans provided a fairness opinion to the Board. 9496 7346 Quebec Inc. is acting as financial advisor to VidaCann and Cobb Cole, P.A. is acting as U.S. counsel. Reported Earnings • Aug 11
Second quarter 2023 earnings: EPS in line with analyst expectations despite revenue beat Second quarter 2023 results: US$0.02 loss per share (further deteriorated from US$0.009 loss in 2Q 2022). Revenue: US$25.8m (down 9.1% from 2Q 2022). Net loss: US$4.35m (loss widened 113% from 2Q 2022). Revenue is forecast to grow 28% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Pharmaceuticals industry in Canada. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has fallen by 44% per year, which means it is performing significantly worse than earnings. Tillkännagivande • Aug 01
Planet 13 Holdings Inc. to Report Q2, 2023 Results on Aug 09, 2023 Planet 13 Holdings Inc. announced that they will report Q2, 2023 results After-Market on Aug 09, 2023 Recent Insider Transactions Derivative • May 29
Vice President of Operations exercised options to buy CA$73k worth of stock. On the 25th of May, Christopher Wren exercised 156.52k options to receive shares at no cost, then sold around 57.91k of them at CA$0.76 each and kept the remainder. Since June 2022, Christopher's direct individual holding has increased from 4.24m shares to 4.34m. Company insiders have collectively bought CA$147k more than they sold, via options and on-market transactions, in the last 12 months. Reported Earnings • May 17
First quarter 2023 earnings: Revenues and EPS in line with analyst expectations First quarter 2023 results: US$0.029 loss per share (further deteriorated from US$0.01 loss in 1Q 2022). Revenue: US$24.9m (down 3.0% from 1Q 2022). Net loss: US$6.30m (loss widened 206% from 1Q 2022). Revenue is forecast to grow 23% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Pharmaceuticals industry in Canada. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has only fallen by 19% per year, which means it has not declined as severely as earnings. Tillkännagivande • May 13
Planet 13 Holdings Inc., Annual General Meeting, Jul 27, 2023 Planet 13 Holdings Inc., Annual General Meeting, Jul 27, 2023. Tillkännagivande • May 11
Planet 13 Holdings Inc. Announces Board Changes Planet 13 Holdings Inc. announced the appointment of Lee Fraser as a Board Member and the new Audit Committee Chair to fill the vacancy created by the passing of Mike Harman. Mr. Fraser will also serve on the Corporate Governance and Nominating Committee and Compensation Committee of the Board. Mr. Fraser is an accomplished CFO and finance and accounting executive with over 20 years of experience at publicly traded companies and private businesses. He has overseen financial reporting, large-scale construction projects and managed real estate portfolios for renowned companies, such as Warner Bros., Fox Corp. and many others. In his role as Audit Committee Chair and Board Member, Mr. Fraser will bring his wealth of experience and knowledge to oversee and guide the organization's audit processes, financial reporting, and internal controls. The company expects his strategic insights, construction and real estate knowledge and commitment to excellence will contribute to the overall success and governance of the organization as Planet 13 continues to expand its operations into more states. The appointment remains subject to regulatory background investigations. Mr. Fraser holds an MBA from UCLA Anderson School of Management and a Hon. Bachelor of Commerce from Telfer School of Management, University of Ottawa, Canada. Tillkännagivande • May 04
Planet 13 Holdings Inc. to Report Q1, 2023 Results on May 15, 2023 Planet 13 Holdings Inc. announced that they will report Q1, 2023 results After-Market on May 15, 2023 Reported Earnings • Mar 25
Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind Full year 2022 results: US$0.23 loss per share (further deteriorated from US$0.10 loss in FY 2021). Revenue: US$104.6m (down 13% from FY 2021). Net loss: US$49.0m (loss widened 152% from FY 2021). Revenue exceeded analyst estimates by 1.0%. Earnings per share (EPS) missed analyst estimates. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Pharmaceuticals industry in Canada. Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings. Tillkännagivande • Feb 08
Planet 13 Holdings Inc. agreed to acquire the remaining 51% stake in Planet 13 Illinois, LLC from Frank Cowan for approximately $1.82. Planet 13 Holdings Inc. entered into an agreement to acquire the remaining 51% stake in Planet 13 Illinois, LLC from Frank Cowan for approximately $1.82 million on February 7, 2022. Planet 13 Holdings Inc. will purchase the remaining 51% in Planet 13 Illinois, LLC ("Planet 13 Illinois") from Frank Cowan for $0.866250 million in cash and 1.063377 million common shares of Planet 13 (the "Planet 13 Shares") pursuant to an option purchase agreement entered into on August 4, 2022. As at the August 4, 2022 option agreement date and February 7, 2023 option exercise date, the Planet 13 Shares were valued at $2 million and $0.950021 million, respectively, based on 5-day volume-weighted average prices. The Planet 13 Shares will be subject to a four month and one day hold period under Canadian securities laws and a minimum of six months following the date of issuance for resales under Rule 144 promulgated under the U.S. Securities Act of 1933 (assuming all other requirements of Rule 144 are satisfied at such time), and following such six month period will be subject to a lock-up whereby 1/12 of the Planet 13 Shares will be released each month thereafter in accordance with a lock up agreement with Frank Cowan. Construction at the dispensary is underway with an opening date anticipated later this year. Planet 13 has received all local and state approvals, excluding final approval upon completion of construction. Major Estimate Revision • Nov 17
Consensus EPS estimates fall by 23% The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from US$108.0m to US$103.1m. Losses expected to increase from US$0.06 per share to US$0.08. Pharmaceuticals industry in Canada expected to see average net income growth of 4.4% next year. Consensus price target down from CA$2.58 to CA$2.29. Share price was steady at CA$1.72 over the past week. Board Change • Nov 16
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. Independent Director Adrienne O’Neal was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Nov 12
Third quarter 2022 earnings: EPS and revenues miss analyst expectations Third quarter 2022 results: US$0.028 loss per share (improved from US$0.043 loss in 3Q 2021). Revenue: US$25.6m (down 22% from 3Q 2021). Net loss: US$6.26m (loss narrowed 26% from 3Q 2021). Revenue missed analyst estimates by 9.8%. Earnings per share (EPS) also missed analyst estimates by 50%. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Pharmaceuticals industry in Canada. Over the last 3 years on average, earnings per share has fallen by 6% per year whereas the company’s share price has fallen by 5% per year. Tillkännagivande • Nov 05
Planet 13 Holdings Inc. to Report Q3, 2022 Results on Nov 10, 2022 Planet 13 Holdings Inc. announced that they will report Q3, 2022 results After-Market on Nov 10, 2022 Tillkännagivande • Nov 03
Planet 13 Announces Illinois Dispensary Location Planet 13 Holdings Inc. announced it has submitted its proposed Illinois location in Fountain Square, Waukegan, Illinois to the Illinois Department of Financial & Professional Regulation ("IDFPR") and local regulators for approval. The build-out and opening for the location is conditioned on approvals from Illinois state regulators and the City of Waukegan. The Company will continue to provide updates as appropriate. Major Estimate Revision • Aug 22
Consensus forecasts updated The consensus outlook for 2022 has been updated. 2022 revenue forecast fell from US$124.6m to US$108.0m. EPS estimate increased from -US$0.07 to -US$0.06 per share. Pharmaceuticals industry in Canada expected to see average net income growth of 4.5% next year. Consensus price target down from CA$3.52 to CA$2.63. Share price fell 23% to CA$1.91 over the past week. Reported Earnings • Aug 17
Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind Second quarter 2022 results: US$0.009 loss per share (up from US$0.028 loss in 2Q 2021). Revenue: US$28.4m (down 14% from 2Q 2021). Net loss: US$2.04m (loss narrowed 63% from 2Q 2021). Revenue missed analyst estimates by 8.2%. Earnings per share (EPS) exceeded analyst estimates by 60%. Over the next year, revenue is forecast to grow 5.4%, compared to a 25% growth forecast for the Pharmaceuticals industry in Canada. Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings. 
